Seeing Is Believing
Currently, out of the existing stock ratings of Emmanuel Papadakis - 3 which are a Sell (9.68%), 6 which are a Hold (19.35%), 22 which are a Buy (70.97%)
Analyst Emmanuel Papadakis works at DEUTSCHE BANK and is covering the Healthcare sector with 169 price targets and ratings displayed on 14 stocks. Previously, Emmanuel Papadakis worked at BARCLAYS.
Emmanuel Papadakis's average stock forecast success ratio is 48.2% with an average time for price targets to be met of 47.91 days.
Most recent stock forecast was given on MRNA, Moderna at 03-Aug-2023.
Analyst best performing recommendations are on ALVO.
The best stock recommendation documented was for MRNA (MODERNA) at 3/7/2022. The price target of $155 was fulfilled within 9 days with a profit of $28.54 (22.57%) receiving and performance score of 25.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
120.34
2 months 7 days ago
0/2 (0%)
$56.72 (106.69%)
Hold
2 months 9 days ago
0/2 (0%)
$56.95 (106.34%)
Buy
158.61
2 months 16 days ago
0/3 (0%)
$77.98 (168.75%)
Buy
80
$12.04 (17.72%)
85
3 months 26 days ago
1/3 (33.33%)
$9.27 (13.19%)
232
Buy
6 months 6 days ago
0/3 (0%)
$83.57 (142.93%)
Which stock is Emmanuel Papadakis is most bullish on?
Which stock is Emmanuel Papadakis is most reserved on?
What Year was the first public recommendation made by Emmanuel Papadakis?